Crossmark

Risk-related short-term clinical outcomes after transcatheter aortic valve implantation and their impact on early mortality: an analysis of claims-based data from Germany

Crossref DOI link: https://doi.org/10.1007/s00392-022-02009-y

Published Online: 2022-03-24

Published Print: 2022-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Schofer, Niklas https://orcid.org/0000-0001-5190-813X
Jeschke, Elke

Kröger, Janine

Baberg, Henning

Falk, Volkmar

Gummert, Jan F.

Hamm, Christian W.

Möckel, Martin

Goßling, Alina

Malzahn, Jürgen

Günster, Christian

Blankenberg, Stefan
Funding

Funding for this research was provided by:

Universitätsklinikum Hamburg-Eppendorf (UKE)
License Information

Text and Data Mining valid from 2022-03-24

Version of Record valid from 2022-03-24
More Information

Article History

Received: 18 November 2021

Accepted: 8 March 2022

First Online: 24 March 2022

Change Date: 24 July 2022

Change Type: Update

Change Details: In this article the following funding information was added: Open Access funding enabled and organized by Projekt DEAL.

Declarations

:

: NS received travel compensation from Edwards Lifesciences and St. Jude Medical, as well as speaker honoraria and travel compensation from Boston Scientific. CH is member of the International Advisory Board for Medtronic. All other authors report no conflict of interest.

Document is current

Any future updates will be listed below